These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 22430044

  • 1. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women.
    Papierska L, Rabijewski M, Kasperlik-Załuska A, Zgliczyński W.
    Adv Med Sci; 2012 Jun 01; 57(1):51-7. PubMed ID: 22430044
    [Abstract] [Full Text] [Related]

  • 2. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 01; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 3. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
    Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS.
    J Clin Endocrinol Metab; 2002 Nov 01; 87(11):4935-41. PubMed ID: 12414853
    [Abstract] [Full Text] [Related]

  • 4. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
    Genazzani AD, Stomati M, Strucchi C, Puccetti S, Luisi S, Genazzani AR.
    Fertil Steril; 2001 Aug 01; 76(2):241-8. PubMed ID: 11476767
    [Abstract] [Full Text] [Related]

  • 5. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP.
    J Bone Miner Res; 2001 Jan 01; 16(1):104-12. PubMed ID: 11149473
    [Abstract] [Full Text] [Related]

  • 6. Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.
    Cauza E, Etemad M, Winkler F, Hanusch-Enserer U, Partsch G, Noske H, Dunky A.
    J Clin Pharm Ther; 2004 Oct 01; 29(5):431-6. PubMed ID: 15482386
    [Abstract] [Full Text] [Related]

  • 7. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE, Sanchez S, Genant HK, Jenkins DK, Arnaud CD.
    Osteoporos Int; 2000 Oct 01; 11(5):434-42. PubMed ID: 10912846
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR, Ventz M, Diederich S, Quinkler M.
    J Clin Endocrinol Metab; 2012 Jan 01; 97(1):85-92. PubMed ID: 21994966
    [Abstract] [Full Text] [Related]

  • 9. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.
    Jankowski CM, Gozansky WS, Kittelson JM, Van Pelt RE, Schwartz RS, Kohrt WM.
    J Clin Endocrinol Metab; 2008 Dec 01; 93(12):4767-73. PubMed ID: 18812486
    [Abstract] [Full Text] [Related]

  • 10. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U, Teichmann J, Müller-Ladner U, Strunk J.
    Rheumatology (Oxford); 2005 Dec 01; 44(12):1546-8. PubMed ID: 16263785
    [Abstract] [Full Text] [Related]

  • 11. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial.
    von Mühlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R.
    Osteoporos Int; 2008 May 01; 19(5):699-707. PubMed ID: 18084691
    [Abstract] [Full Text] [Related]

  • 12. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 01; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 13. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
    Labrie F, Diamond P, Cusan L, Gomez JL, Bélanger A, Candas B.
    J Clin Endocrinol Metab; 1997 Oct 01; 82(10):3498-505. PubMed ID: 9329392
    [Abstract] [Full Text] [Related]

  • 14. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men.
    Villareal DT, Holloszy JO, Kohrt WM.
    Clin Endocrinol (Oxf); 2000 Nov 01; 53(5):561-8. PubMed ID: 11106916
    [Abstract] [Full Text] [Related]

  • 15. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD.
    J Bone Miner Res; 2000 May 01; 15(5):944-51. PubMed ID: 10804025
    [Abstract] [Full Text] [Related]

  • 16. Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat.
    Luo S, Labrie C, Bélanger A, Labrie F.
    Endocrinology; 1997 Aug 01; 138(8):3387-94. PubMed ID: 9231792
    [Abstract] [Full Text] [Related]

  • 17. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover].
    Celi M, Balducci S, Schiappoli A, Caliumi C, Petramala L, Cerci S, Cotesta D, D'Erasmo E, Letizia C.
    Ann Ital Med Int; 2003 Aug 01; 18(2):89-98. PubMed ID: 12886826
    [Abstract] [Full Text] [Related]

  • 18. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
    Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, Van Pelt RE, Kohrt WM.
    J Clin Endocrinol Metab; 2006 Aug 01; 91(8):2986-93. PubMed ID: 16735495
    [Abstract] [Full Text] [Related]

  • 19. Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials.
    Jankowski CM, Wolfe P, Schmiege SJ, Nair KS, Khosla S, Jensen M, von Muhlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R, Weiss EP, Villareal DT, Kohrt WM.
    Clin Endocrinol (Oxf); 2019 Feb 01; 90(2):293-300. PubMed ID: 30421439
    [Abstract] [Full Text] [Related]

  • 20. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T, Miyatani Y, Tomita J, Yamada M, Uemura H, Miura M, Irahara M.
    Gynecol Endocrinol; 2006 Aug 01; 22(8):455-9. PubMed ID: 17012108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.